Acuta Capital Partners, LLC Pyxis Oncology, Inc. Transaction History

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.88 - $3.03 $45,136 - $72,747
24,009 Added 3.72%
669,158 $1.32 Million
Q2 2022

Aug 15, 2022
BUY
$2.02 - $4.53 $899,200 - $2.02 Million
445,149 Added 222.57%
645,149 $1.54 Million
Q1 2022

May 16, 2022
SELL
$4.04 - $11.43 $1.93 Million - $5.46 Million
-477,753 Reduced 70.49%
200,000 $808,000
Q4 2021

Feb 14, 2022
BUY
$8.39 - $13.64 $5.69 Million - $9.24 Million
677,753 New
677,753 $7.44 Million

Others Institutions Holding PYXS

# of Institutions
101
Shares Held
28.2M
Call Options Held
539K
Put Options Held
54.1K
View Full List

About Pyxis Oncology, Inc.

PYXS Quotes by TradingView
  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email